MEDSCINT and RADICARE sign distribution agreement for plastic scintillation dosimetry in BENELUX
Quebec (CANADA), April 23rd, 2024 – The leading provider of quality assurance (QA) scintillation dosimetry solutions for radiation therapy MEDSCINT has entered into a distribution agreement with Radicare, a major and trusted independent provider of medical equipment and software to the radiotherapy community. Under the distribution agreement, Radicare will market and sell MEDSCINT HYPERSCINT™ solutions for research use to institutions in The Netherlands, Belgium, and Luxembourg regions (BENELUX).
The MEDSCINT patented HYPERSCINT™ real-time dose measurement detector sets the standard for accuracy in demanding radiotherapy applications such as dosimetry of small-fields, real-time adaptive QA (ex. MR-Linac) and ultra-high dose rate irradiation protocols (UHDR or FLASH-RT).
Unique features include:
- Fast real-time dose measurements at multiple locations, simultaneously.
- Water-equivalent detector, improving measurement accuracy without perturbation nor correction factors.
- Miniature sensitive volume (down to 0.1 mm³), providing sharp spatial resolution.
- Unique hyperspectral Cherenkov/stem removal technique, enabling robust angular independence on 4π.
- Linear response over a wide range of dose rates (from out-of-field to ultra-high dose rates).
- Metal-free detector design, eliminating artifacts when used in high-strength magnetic fields.
“We help medical physicists understand, develop and deploy modern radiation therapy techniques by providing a new generation of versatile optical dosimetry solutions. Our sales are on the growth path, and this new partnership will allow us to expand our geographic reach and support our customers in Belgium, The Netherlands and Luxembourg region,” says Jonathan Turcotte, Co-founder and Chief Marketing Officer at Medscint.
“We offer a wide range of top-notch equipment specifically designed to make Radiotherapy treatments more precise and effective, and plastic scintillation detectors from MEDSCINT proved to deliver outstanding performances. We are thrilled to give access to our customer base to such innovative and promising technology,”adds Patrick Hylkema, Founder and CEO at Radicare.
About Radicare
Radicare is offering a wide range of top-notch solutions specially designed to make Radiotherapy treatments more precise and effective. Our focus is always on providing the best care for patients. We are passionate about making groundbreaking advances in Radiotherapy, and doing so with a patient-first approach. We take the meaningful route and therefore happy to work with Medscint! For more information, visit www.radicare.eu. Media Contact: Radicare Montenslaan 9, 4837 CE Breda – The Netherlands. Patrick Hylkema Founder and CEO. 00316 10537477 | info@radicare.eu.
About Medscint
Founded in 2018, Medscint is a Canadian-based company that partners with the experts in the field to push the limits of innovation in radiotherapy. They aim at facilitating the work of medical physicists and researchers worldwide with their versatile, cutting-edge optics and photonics technology. For more information, visit www.medscint.com. Media Contact: Medscint Inc. 1405, Parc Technologique Québec, QC G1l4P5 – CANADA. Jonathan Turcotte, Eng. MBA Co-founder and Chief Marketing Officer. 1-888-901-6521 | info@medscint.com.